Literature search results

347 articles were found.

The following terms were included: glioblastoma, Glioblastom, 神経膠細胞芽腫

• 2023, Li X, Liu K, Xing L, Rubinsky B
  A review of tumor treating fields (TTFields): advancements in clinical applications and mechanistic insights [review]
  Radiol Oncol 57 (3): 279-291
• 2023, Cerna M, Drizdal T
  Implementation of Time Reversal Focusing on Hyperthermia Treatment of Brain Tumours [tech./dosim.]
  2023 Photonics & Electromagnetics Research Symposium (PIERS), Prague, Czech Republic. IEEE: pp. 1267-1274; ISBN 9798350312850
• 2023, Ballo MT, Conlon P, Lavy-Shahaf G, Kinzel A, Vymazal J, Rulseh AM
  Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis [review]
  J Neurooncol 164 (1): 1-9
• 2023, Barkhoudarian G, Badruddoja M, Blondin N, Chowdhary S, Cobbs C, Duic JP, Flores JP, Fonkem E, McClay E, Nabors LB, Salacz M, Taylor L, Vaillant B, Gill J, Kesari S
  An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma [med. app.]
  CNS Oncol 12 (3): CNS102
• 2023, Mehdizadeh R, Madjid Ansari A, Forouzesh F, Shahriari F, Shariatpanahi SP, Salaritabar A, Javidi MA
  P53 status, and G2/M cell cycle arrest, are determining factors in cell-death induction mediated by ELF-EMF in glioblastoma [med./bio.]
  Sci Rep 13: 10845
• 2023, Yoshikawa MH, Rabelo NN, Telles JPM, Figueiredo EG
  [details] Modifiable risk factors for glioblastoma: a systematic review and meta-analysis [review]
  Neurosurg Rev 46 (143): 143
• 2023, Fishman H, Monin R, Dor-On E, Kinzel A, Haber A, Giladi M, Weinberg U, Palti Y
  Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines [med./bio.]
  J Neurooncol 163 (1): 83-94
• 2023, Abed T, Ganser K, Eckert F, Stransky N, Huber SM
  Ion channels as molecular targets of glioblastoma electrotherapy [review]
  Front Cell Neurosci 17: 1133984
• 2023, Zhou Y, Xing X, Zhou J, Jiang H, Cen P, Jin C, Zhong Y, Zhou R, Wang J, Tian M, Zhang H
  Therapeutic potential of tumor treating fields for malignant brain tumors [review]
  Cancer Rep 6 (5): e1813
• 2023, Smothers AR, Henderson JR, O'Connell JJ, Stenbeck JM, Dean D, Harvey TG, Booth BW
  Efficacy and selectivity of tumor-treating field therapy for triple-negative breast cancer cells via in-house delivery device [med./bio.]
  Discov Oncol 14 (1): 34
• 2023, Cruz N, Herculano-Carvalho M, Roque D, Faria CC, Cascão R, Ferreira HA, Reis CP, Matela N
  Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma [review]
  Pharmaceutics 15 (3): 928
• 2023, Isaković J, Šerer K, Barišić B, Mitrečić D
  Mesenchymal stem cell therapy for neurological disorders: The light or the dark side of the force? [basics]
  Front Bioeng Biotechnol 11: 1139359
• 2023, Lin L, McCraw MR, Uluutku B, Liu Y, Yan D, Soni V, Horkowitz A, Yao X, Limanowski R, Solares SD, Beilis II, Keidar M
  Cell Membrane Oscillations under Radiofrequency Electromagnetic Modulation [med./bio.]
  Langmuir 39 (9): 3320-3331
• 2023, Ravin R, Cai TX, Li A, Briceno N, Pursley RH, Garmendia-Cedillos M, Pohida T, Wang H, Zhuang Z, Cui J, Morgan NY, Williamson NH, Gilbert MR, Basser PJ
  "Tumor Treating Fields" delivered via electromagnetic induction have varied effects across glioma cell lines and electric field amplitudes [med./bio.]
  bioRxiv: the Preprint Server for Biology (bioRxiv), 2023.01.18.524504
• 2023, Wu H, Liu L, Ma M, Zhang Y
  Modulation of blood-brain tumor barrier for delivery of magnetic hyperthermia to brain cancer [med./bio.]
  J Control Release 355: 248-258
• 2023, Gökçek-Saraç Ç, Şimşek T, Karakurt S
  Cytoprotective effects of low-frequency pulsed electromagnetic field against oxidative stress in glioblastoma cells [med./bio.]
  Gen Physiol Biophys 42 (1): 97-106
• 2023, Yahyapour R, Khoei S, Kordestani Z, Larizadeh MH, Jomehzadeh A, Amirinejad M, Ahmadi-Zeidabadi M
  Comparative study of extremely low-frequency electromagnetic field, radiation, and temozolomide administration in spheroid and monolayer forms of the glioblastoma cell line (T98) [med./bio.]
  Curr Radiopharm 16 (2): 123 - 132
• 2023, Sitnikov DS, Revkova VA, Ilina IV, Gurova SA, Komarov PS, Struleva EV, Konoplyannikov MA, Kalsin VA, Baklaushev VP
  Studying the genotoxic effects of high intensity terahertz radiation on fibroblasts and CNS tumor cells [med./bio.]
  J Biophotonics 16 (1): e202200212
• 2023, Jin T, Dou Z, Zhao Y, Jiang B, Xu J, Zhang B, Wei B, Dong F, Zhang J, Sun C
  Skull defect increases the tumor treating fields strength without detrimental thermogenic effect: A computational simulating research [tech./dosim.]
  Cancer Med 12 (2): 1461-1470
• 2022, Salvador E, Kessler AF, Domröse D, Hörmann J, Schaeffer C, Giniunaite A, Burek M, Tempel-Brami C, Voloshin T, Volodin A, Zeidan A, Giladi M, Ernestus RI, Löhr M, Förster CY, Hagemann C
  Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood-Brain Barrier In Vitro and In Vivo [med./bio.]
  Biomolecules 12 (10): 1348
• 2022, Shams S, Patel CB
  Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields]) [review]
  J Mol Cell Biol 14 (8): mjac047
• 2022, Vymazal J, Kazda T, Novak T, Slanina P, Sroubek J, Klener J, Hrbac T, Syrucek M, Rulseh AM
  Eighteen years' experience with tumor treating fields in the treatment of newly diagnosed glioblastoma [med. app.]
  Front Oncol 12: 1014455
• 2022, Anadkat MJ, Lacouture M, Friedman A, Horne ZD, Jung J, Kaffenberger B, Kalmadi S, Ovington L, Kotecha R, Abdullah HI, Grosso F
  Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region [basics]
  Front Oncol 12: 975473
• 2022, Du X, Chen C, Xiao Y, Cui Y, Yang L, Li X, Liu X, Wang R, Tan B
  Research on application of tumor treating fields in glioblastoma: A bibliometric and visual analysis [review]
  Front Oncol 12: 1055366
• 2022, Foo CY, Munir N, Kumaria A, Akhtar Q, Bullock CJ, Narayanan A, Fu RZ
  Medical Device Advances in the Treatment of Glioblastoma [review]
  Cancers 14 (21): 5341
• 2022, Moser JC, Salvador E, Deniz K, Swanson K, Tuszynski J, Carlson KW, Karanam NK, Patel CB, Story M, Lou E, Hagemann C
  The Mechanisms of Action of Tumor Treating Fields [basics]
  Cancer Res 82 (20): 3650-3658
• 2022, Kumaria A
  Observations on the anti-glioma potential of electrical fields: is there a role for surgical neuromodulation? [basics]
  Br J Neurosurg 36 (5): 564-568
• 2022, Jain A, Jobson I, Griffin M, Rahman R, Smith S, Rawson FJ
  Electric field responsive nanotransducers for glioblastoma [med./bio.]
  Bioelectron Med 8: 17
• 2022, Tanzhu G, Chen L, Xiao G, Shi W, Peng H, Chen D, Zhou R
  The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy [review]
  Cell Death Discov 8: 416
• 2022, Hambarde S, Nguyen L, Manalo J, John B, Baskin DS, Helekar SA
  Method for noninvasive whole-body stimulation with spinning oscillating magnetic fields and its safety in mice [med./bio.]
  Electromagn Biol Med 41 (4): 419-428
• 2022, Pandey M, Xiu J, Mittal S, Zeng J, Saul M, Kesari S, Azadi A, Newton H, Deniz K, Ladner K, Sumrall A, Korn WM, Lou E
  Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields [med./bio.]
  Neurooncol Adv 4 (1): vdac096
• 2022, Le HT, Staelens M, Lazzari D, Chan G, Tuszyński JA
  Real-Time Monitoring of the Effect of Tumour-Treating Fields on Cell Division Using Live-Cell Imaging [med./bio.]
  Cells 11 (17): 2712
• 2022, Lefevre MC, Kaszas A, Dijk G, Baca M, Baudino O, Marchiori B, Kergoat L, Moreau D, Debarbieux F, O'Connor RP
  Flexible Organic Electronic Devices for Pulsed Electric Field Therapy of Glioblastoma [tech./dosim.]
  J Vis Exp (186): e63527
• 2022, Redr J, Pokorny T, Drizdal T, Fiser O, Brunat M, Vrba J, Vrba D
  Microwave Hyperthermia of Brain Tumors: A 2D Assessment Parametric Numerical Study [tech./dosim.]
  Sensors 22 (16): 6115
• 2022, Guo X, Yang X, Wu J, Yang H, Li Y, Li J, Liu Q, Wu C, Xing H, Liu P, Wang Y, Hu C, Ma W
  Tumor-Treating Fields in Glioblastomas: Past, Present, and Future [review]
  Cancers 14 (15): 3669
• 2022, Gentilal N, Abend E, Naveh A, Marciano T, Balin I, Telepinsky Y, Miranda PC
  Temperature and Impedance Variations During Tumor Treating Fields (TTFields) Treatment [tech./dosim.]
  Front Hum Neurosci 16: 931818
• 2022, Ye E, Lee JE, Lim YS, Yang SH, Park SM
  [Corrigendum] Effect of duty cycles of tumor‑treating fields on glioblastoma cells and normal brain organoids [erratum]
  Int J Oncol 61 (3): 107
• 2022, Bergandi L, Lucia U, Grisolia G, Salaroglio IC, Gesmundo I, Granata R, Borchiellini R, Ponzetto A, Silvagno F
  Thermomagnetic Resonance Effect of the Extremely Low Frequency Electromagnetic Field on Three-Dimensional Cancer Models [med./bio.]
  Int J Mol Sci 23 (14): 7955
• 2022, Lee WS, Kim EH
  Combination therapy of Doxorubicin with TTFields and radiation: newer approaches to combat lung cancer [med./bio.]
  Am J Cancer Res 12 (6): 2673-2685
• 2022, Iredale E, Voigt B, Rankin A, Kim KW, Chen JZ, Schmid S, Hebb MO, Peters TM, Wong E
  Planning System for the Optimization of Electric Field Delivery using Implanted Electrodes for Brain Tumor Control [tech./dosim.]
  Med Phys 49 (9): 6055-6067
• 2022, Catanzaro D, Milani G, Bozza A, Bernardi M, Chieregato K, Menarin M, Merlo A, Celli P, Belli R, Peroni D, Pozzato A, Pozzato G, Raneri FA, Volpin L, Ruggeri M, Astori G
  Selective cell cycle arrest in glioblastoma cell lines by quantum molecular resonance alone or in combination with temozolomide [med./bio.]
  Br J Cancer 127 (5): 824-835
• 2022, Lange F, Venus J, Shams Esfand Abady D, Porath K, Einsle A, Sellmann T, Neubert V, Reichart G, Linnebacher M, Köhling R, Kirschstein T
  Galvanotactic Migration of Glioblastoma and Brain Metastases Cells [med./bio.]
  Life 12 (4): 580
• 2022, Shi P, Tian J, Ulm BS, Mallinger JC, Khoshbouei H, Deleyrolle LP, Sarkisian MR
  Tumor Treating Fields Suppression of Ciliogenesis Enhances Temozolomide Toxicity [med./bio.]
  Front Oncol 12: 837589
• 2022, Schüz J, Pirie K, Reeves GK, Floud S, Beral V, Million Women Study Collaborators
  Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study [epidem.]
  J Natl Cancer Inst 114 (5): 704-711
• 2022, Chen D, Le SB, Hutchinson TE, Calinescu AA, Sebastian M, Jin D, Liu T, Ghiaseddin A, Rahman M, Tran DD
  Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma [med./bio.]
  J Clin Invest 132 (8): e149258
• 2022, Branter J, Estevez-Cebrero M, Diksin M, Griffin M, Castellanos-Uribe M, May S, Rahman R, Grundy R, Basu S, Smith S
  Genome-Wide Expression and Anti-Proliferative Effects of Electric Field Therapy on Pediatric and Adult Brain Tumors [med./bio.]
  Int J Mol Sci 23 (4): 1982
• 2022, Gött H, Kiez S, Dohmen H, Kolodziej M, Stein M
  Tumor treating fields therapy is feasible and safe in a 3-year-old patient with diffuse midline glioma H3K27M - a case report [med. app.]
  Childs Nerv Syst 38 (9): 1791-1796
• 2022, Senturk F, Cakmak S, Kocum IC, Gumusderelioglu M, Ozturk GG
  Effects of radiofrequency exposure on in vitro blood-brain barrier permeability in the presence of magnetic nanoparticles [med./bio.]
  Biochem Biophys Res Commun 597: 91-97
• 2022, Ye E, Lee JE, Lim YS, Yang SH, Park SM
  Effect of duty cycles of tumor‑treating fields on glioblastoma cells and normal brain organoids [med./bio.]
  Int J Oncol 60 (1): 8
• 2022, Rominiyi O, Collis SJ
  DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies [review]
  Mol Oncol 16 (1): 11-41